PubMatic (NASDAQ:PUBM – Free Report) had its price objective upped by Rosenblatt Securities from $21.00 to $23.00 in a report published on Friday morning, MarketBeat.com reports. They currently have a buy rating on the stock. Other equities research analysts have also recently issued reports about the company. Scotiabank raised PubMatic from a “sector perform” rating […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Genmab A/S (NASDAQ:GMAB) Price Target Raised to $42.00 | 0 | 9.76 | 10-08-2026 |
| 2 | Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00 | 0 | 13.83 | 10-08-2026 |
| 3 | BP (NYSE:BP) Price Target Raised to $43.00 | 0 | 12.22 | 10-08-2026 |
| 4 | Marathon Digital’s (MARA) “Buy” Rating Reiterated at Rosenblatt Securities | 0 | 7.71 | 10-08-2026 |
| 5 | Microchip Technology’s (MCHP) Buy Rating Reiterated at Rosenblatt Securities | 0 | 7.99 | 10-08-2026 |
| 6 | BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $60.00 | 0 | 12.21 | 10-08-2026 |
| 7 | Texas Roadhouse (NASDAQ:TXRH) Price Target Raised to $220.00 | 0 | 11.48 | 10-08-2026 |
| 8 | Universal Electronics’ (UEIC) Neutral Rating Reiterated at Rosenblatt Securities | 0 | 8.86 | 10-08-2026 |
| 9 | Rosenblatt Securities Cuts Atlanta Braves (NASDAQ:BATRK) Price Target to $73.00 | 0 | 11.83 | 10-08-2026 |
| 10 | Valaris (NYSE:VAL) Price Target Raised to $80.00 | 0 | 10.77 | 10-08-2026 |